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Abstract
Invasion of host cells by the malaria parasite involves recognition and interaction with cell-surface receptors. A wide variety
of parasite surface proteins participate in this process, most of which are specific to the parasite’s particular invasive form.
Upon entry, the parasite has to dissociate itself from the host-cell receptors. One mechanism by which it does so is by
shedding its surface ligands using specific enzymes. Rhomboid belongs to a family of serine proteases that cleave cell-
surface proteins within their transmembrane domains. Here we identify and partially characterize a Plasmodium berghei
rhomboid protease (PbROM1) that plays distinct roles during parasite development. PbROM1 localizes to the surface of
sporozoites after salivary gland invasion. In blood stage merozoites, PbROM1 localizes to the apical end where proteins
involved in invasion are also present. Our genetic analysis suggests that PbROM1 functions in the invasive stages of parasite
development. Whereas wild-type P. berghei is lethal to mice, animals infected with PbROM1 null mutants clear the parasites
efficiently and develop long-lasting protective immunity. The results indicate that P. berghei Rhomboid 1 plays a
nonessential but important role during parasite development and identify rhomboid proteases as potential targets for
disease control.
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Introduction
For successful development and transmission, Plasmodium has to
invade multiple cell types both in the mammalian host and in the
mosquito vector. Much of our knowledge about the molecular
mechanisms of invasion comes from the study of P. falciparum
merozoite invasion of red blood cells (RBCs). RBC invasion
involves an initial attachment followed by re-orientation and entry
of the parasite into the host cell [1]. There are two main classes of
parasite surface molecules, the GPI-anchored proteins such as the
merozoite surface protein family (MSP) [2] and transmembrane
domain-containing proteins such as AMA1 [3,4], erythrocyte
binding-like family (EBL) [5,6] and reticulocyte binding-like family
proteins (RBL) [7,8]. A few host-cell receptors to which these
ligands bind have been identified [9–12].
In the mosquito, motility plays an important role in ookinete
and sporozoite invasion. Motile ookinetes form within the
mosquito blood meal and invade the midgut epithelium. After
exiting on the basal side facing the hemocoel they differentiate into
sessile oocysts [13]. Subsequently, sporozoites released from
mature oocysts invade the salivary glands from where they are
delivered to the vertebrate host by a mosquito bite. These
sporozoites travel through the blood stream until they reach the
liver, where they invade and infect hepatocytes. All three invasive
forms (ookinetes, sporozoites in the mosquito and sporozoites in
the mammalian host) utilize the same actin-based motor for entry
into the host cell. Thrombospondin-related anonymous protein
(TRAP) family homologues constitute one class of protein required
for motility and host cell invasion [14–16]. The extracellular
domains of TRAP interact with host-cell receptors, while the
cytoplasmic tail links to the actin-myosin cytoskeleton [17]. As the
parasite glides, the parasite surface ligand-receptor complexes
translocate towards the posterior end. Dissociation of these
interactions by proteolytic processing is thought to be important,
as this enables the parasite to move forward [18–20]. In another
Apicomplexan parasite-Toxoplasma-the TRAP homologue MIC2 is
cleaved within its transmembrane domain releasing the receptor-
binding domain from the parasite surface [18] and Plasmodium
merozoite TRAP (MTRP) also appears to be cleaved in a similar
manner [16].
Rhomboid-family (ROM) proteins are serine proteases that
cleave their substrates within their membrane domain [21,22].
Multiple rhomboid-family proteins have been identified in the
genomes of Plasmodium and Toxoplasma [23]. Cleavage requires the
presence of helix-destabilizing residues within the membrane
domain of substrates [24]. Indeed, Apicomplexan surface proteins
such as EBL and RBL proteins, AMA1, TRAP and their
homologues contain such helix-destabilizing residues [23]. Assays
in cultured mammalian cells identified possible substrates for both
Toxoplasma and Plasmodium falciparum rhomboid proteins [25,26].
Toxoplasma ROM5 localizes to the posterior end of the parasite and
can cleave MIC2 within its transmembrane domain [25,27].
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to cleave EBA175 [28], an EBL family protein involved in binding
to erythrocytes [10]. Processing of EBA175 within its membrane
domain appears to be essential for parasite invasion [28].
Here we report on experiments investigating the role of
Plasmodium berghei rhomboid 1 (PbROM1) during parasite
development in the vertebrate host and the mosquito vector.
Our data suggests a role for PbROM1 throughout Plasmodium
development and indicate a role in invasion of host cells. We also
find that a null PbROM1 mutant is efficiently cleared from mice
and that these animals are protected from a subsequent lethal
challenge of wild-type P. berghei. These findings identify a unique
target for interfering with both disease causing and disease
transmitting forms of the parasite.
Materials and Methods
Parasite maintenance and mosquito infections were performed
as described previously [29]. We used Anopheles stephensi mosqui-
toes, Plasmodium berghei ANKA 2.34 parasites and female Swiss
Webster mice in all our studies.
PbROM1 antibody production and immunofluorescence
assays
Antibodies were raised in rabbit against the N-terminal 52
amino acids of PbROM1 expressed in bacteria as a fusion protein
using the pBAD expression system (Invitrogen). P. berghei schizonts,
merozoites and sporozoites were fixed in ice-cold methanol and
incubated for 1 h with the anti-PbROM1 antibody diluted 1:500.
Midgut and salivary gland sporozoites were obtained by gently
homogenizing the infected tissues and centrifuging to remove cell
debris. A anti-AMA1 monoclonal antibody (28G2) that recognizes
the highly conserved cytoplasmic tail [30] was also used to label
schizonts and merozoites, while a anti-CSP monoclonal antibody
(3D11) that recognizes the repeat region [31] was used to label
midgut and salivary gland sporozoites. Slides were then incubated
for 1 h with Alexa Fluor 488-conjugated anti-rabbit IgG and
rhodamine-conjugated anti-mouse or anti-rat IgG secondary
antibodies. After washing, images were visualized in a Leica
upright fluorescent microscope with a 1006objective and images
were captured with a SPOT camera.
Immunoelectron microscopy
Sporozoite-infected salivary glands were fixed in 4% parafor-
maldehyde (Electron Microscopy Sciences, PA) in 0.25 M HEPES
(pH7.4) for 1 h at room temperature, followed by 8% parafor-
maldehyde in the same buffer overnight at 4uC. The fixed glands
were permeabilized, frozen and sectioned as previously described
[32]. Sections were immunolabeled with rabbit anti-PbROM1
antibodies (1:20 in PBS/1% fish skin gelatin), then with anti-rabbit
IgG, followed by 10 nm protein A-gold particles (Department of
Cell Biology, Medical School, Utrecht University, the Nether-
lands) before examination with a Philips CM120 Electron
Microscope (Eindhoven, the Netherlands) under 80 kV.
Generation of PbROM1 disruptants
For targeted disruption of the PbROM1 gene, a disruption
plasmid was constructed by PCR amplification with primers,
PbROM1(2)F-59CCATACATTAGCAGAGTATAGGGA39 and
PbROM1(2)R-59ACTTGCAC CCACTTTTATTGTAC39 using
P. berghei genomic DNA as template. Cloning into the P. berghei
transfection vector [33] resulted in plasmid pROM1. This plasmid
was linearized at the unique NdeI site and transfected into P.berghei
schizonts as described [34]. To confirm disruption of the PbROM1
gene, integration-specific PCR was performed using specific primer
combinations, P1-59CGAGCAACAATGTCTGAC39,P 2 -
59GAGTTCATTTTACACAATCC39 and P3-59TAATAC-
GACTCACTATAGGGAGA39. Disruption was also confirmed
by RT-PCR using primers PbROM1F-59TTATTACG-
GAGTGTTTCTTC39 and PbROM1R-59CGGAGAAATACA-
TAGATTA39 P.berghei circumsporozoite gene primers CSF-
59GTACCATTTTAGTTGTAGCGTC39 and CSR-59CATCG-
GCAAGTAATCTGTTG39 were used as positive control.
Phenotypic analysis of PbROM1 disruptants
The ability of the parasites to differentiate into gametocytes and
form male gametes (exflagellation) was assessed as described
previously [35]. An. stephensi mosquitoes were fed on infected mice
and the ability of the disruptant parasites to form ookinetes (24 h)
and oocysts (day 15) was examined microscopically. To assess
ookinete numbers, individual midguts were dissected 24 h after
feeding. Ookinete numbers were calculated after examining a
Giemsa-stained smeared preparation of the midgut contents and
counting both ookinetes and red blood cells. We assumed that
each mosquito ingested 2 ml [36] and that mouse blood has 4610
9
RBCs/ml [37]. Mature oocysts were counted on day 15 by direct
light microscopic examination of dissected midguts. Sporozoites
were isolated from midgut oocysts and salivary glands and counted
on day 25–26 using a hemocytometer.
Gliding motility assay
Sporozoites isolated from salivary glands were incubated for
15 minutes at 37uC in chamber slides coated with BSA. The
supernatant was gently aspirated and sproozoite trails were fixed
with 4% paraformaldehyde. The trails were visualized by labeling
them with anti-CSP (mAb 3D11) antibody and rhodamine
conjugated anti-mouse secondary antibody.
TRAP processing assay
Sporozoites were isolated from salivary glands on ice and
partially purified by passing through glass wool to remove
Author Summary
Malaria is one of the major infectious diseases and is
responsible for the death of more than a million people,
mostly children under the age of five. Plasmodium, the
causative agent of malaria, is transmitted by female
Anopheles mosquitoes. Successful development of the
parasite requires efficient recognition, attachment, and
invasion of host cells. Several parasite cell-surface mole-
cules have been implicated in these processes and may
require proteolytic processing in order for the parasite to
complete invasion. Rhomboid family proteins are serine
proteases that cleave within the transmembrane region of
their substrates. Here, we use a genetic approach to study
the function of Plasmodium berghei rhomboid 1 (PbROM1).
PbROM1 is expressed in both vertebrate and mosquito
stages of parasite development, and the protein is present
in secretory organelles that contain other parasite
molecules required for invasion. We find that PbROM1 is
required for efficient infection of both the mosquito and
the vertebrate host. Interestingly, we also find that mice
infected with ROM1(2) parasites clear the infection
efficiently and are protected upon subsequent wild-type
parasite challenge. Our study suggests a role for PbROM1
throughout parasite development and identifies ROM1 as
a target for disease intervention.
Plasmodium Rhomboid 1 and Malaria
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ketone (TLCK, 20 mM stock in water) and phenylmethylsulfonyl
fluoride (PMSF 100 mM stock in ethanol) were obtained from
Sigma. 30000 sporozoites were incubated at 4uCo r3 7 uC in the
presence or absence of protease inhibitors for 1h. EDTA was used
to rule out nonspecific processing by metalloproteases. Parasite
lysates were run on a SDS-PAGE and transferred onto PVDF
membrane. These were probed with anti-TRAP antibodies that
recognize the repeat region of the protein, followed by peroxidase-
conjugated secondary antibody. To determine TRAP processing
in PbROM1(2) parasites, 30000 wild-type and PbROM1(2)spor-
ozoites were analyzed by SDS-PAGE as mentioned above.
Mice infections with sporozoites
Sporozoites isolated from salivary glands were counted using a
hemocytometer and mice were injected intravenously with 150, 1000
or 10000 sporozoites. Infection efficiency was assayed by monitoring
the pre-patent period of blood stage infection after sporozoite
injection. Prepatent period is the time elapsed between mouse
infection and when the first infected red blood cell (RBC) was
observed upon examination of at least 25,000 RBCs. For quantifying
efficiency of liver infection, mice were injected intravenously with
either 10
3 wild-type or 10
3 PbROM1(2)s p o r o z o i t e s .A n i m a l sw e r e
sacrificed 36–40 h after sporozoite injection and total RNA was
prepared using Trizol reagent. P. berghei 18S rRNA was quantified
using primers (PbrRNA1-59TGGGAGATTGGTTTTGACGT
TTATGT39 and PbrRNA2-59 AAGCATTAAATAAAGCGAA-
TACATCCTTAC39) as described [38] and the results were
normalized using mouse GAPDH. Results from 4 mice per group
are expressed as mean6s.d. of rRNA copy number.
Parasite challenge
Mice were infected with either PbROM1(2) sporozoites or
infected RBCs as described above. Parasitemia was checked every
day until at least 30 days after the last PbROM1(2) parasites was
detected. To confirm complete parasite clearance, 3610
7 RBCs
from these animals were injected into naı ¨ve mice and these
animals were observed for 30 days to ensure that no infection
resulted. After complete remission, the PbROM1(2) infected mice
were challenged by intravenous (iv) or intraperitoneal (ip) injection
of 10
5 wild-type P. berghei iRBCs. A second challenge was
performed either 33 days or 7 months after the first challenge
and a third 9 months after the first. Parasitemia was followed as
described above. Protection is defined as the number of animals
that survive the challenge.
Results
PbROM1 is conserved in all Plasmodium species
Plasmodium berghei ROM1 (PbROM1) was initially identified in a
subtractive hybridization screen for genes expressed during
parasite development in the mosquito [29]. PbROM1 encodes a
protein predicted to have seven transmembrane domains carrying
a conserved, membrane-embedded Asparagine, Glycine-X-Serine
and Histidine ‘‘rhomboid’’ motif (Figure S1). At least seven
rhomboid genes were identified in the genome of various
Plasmodium species [23]. Though PbROM1 homologues are highly
conserved among rodent (92% identity) and human malaria
species (55% identity), sequence identity among rhomboid genes of
a given species is very limited (,20%, data not shown). This points
to independent evolution of different rhomboid genes and suggests
that each rhomboid protein plays distinct functions in the parasite
life cycle.
PbROM1 is expressed in multiple invasive stages
Microarray analysis indicates that PfROM1 is expressed in both
mosquito and vertebrate forms of the parasite [39]. We have
produced an antibody to the first 52-amino acids of PbROM1 and
used it to investigate protein expression and subcellular localiza-
tion. The protein is expressed in both blood- and mosquito-stage
parasites. PbROM1 protein has a punctate distribution in
segmented (mature) schizonts and localizes to the apical end of
free merozoites (Figure 1A). A number of organelles such as
Figure 1. Localization of PbROM1 protein in merozoites and sporozoites. PbROM1 protein expression was assayed by indirect
immunofluorescence (IFA). (A) IFA of fully segmented schizonts and free merozoites, double labeled with anti-PbROM1 (green) and anti-AMA1 (red)
antibodies. (B) IFA of midgut and salivary gland sporozoites double labeled with anti-PbROM1 (green) and anti-CSP (red) antibodies. Little or no
PbROM1 protein can be detected in midgut sporozoites while the protein is distributed in a punctuate pattern throughout salivary gland sporozoites.
DAPI is shown in blue in the merged panels. The dotted line separates the fields of two separate images. PbROM1, P. berghei rhomboid 1, AMA1,
apical membrane antigen 1, CSP, circumsporozoite protein. (Scale bars, 3 mm).
doi:10.1371/journal.ppat.1000262.g001
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merozoite. These organelles secrete parasite proteins involved in
host recognition and invasion. AMA1 (apical membrane antigen 1)
is a micronemal protein required for invasion of RBCs and is also
found on the surface of merozoites (Figure 1A). Immunoelectron
microscopy confirmed the apical localization of PbROM1 and
.85% of the gold label were found in micronemes (Figure 2A and
2B). PbROM1 expression is limited to schizonts and free
merozoites and is not detectable in ring or trophozoite stages
(data not shown). This is in agreement with the microarray
analysis of P. berghei asexual stages in which PbROM1 is induced
only in mature schizonts [40].
In mosquito stages, the PbROM1 transcript was initially
identified among RNAs from mosquito midguts infected with
mature oocysts [29]. Despite this, little or no protein was detected
in sporozoites from these oocysts (Figure 1B). In contrast,
PbROM1 protein is detected in sporozoites after invasion of
mosquito salivary glands (Figure 1B). Immuno-electron microsco-
py more precisely localized PbROM1 in such sporozoites
(Figure 2C and 2D). The protein is present along the entire
length of the sporozoite both on the surface as well as in
micronemes. We examined 65 parasite cryosections to quantify the
distribution of PbROM1 in different cellular locations. Most of the
gold particles were present on the sporozoite plasma membrane
(76.4%) and in the micronemal membrane (17.7%) while the
remaining particles were located over other parasite organelles
(3.3%) and the mosquito salivary duct (2.6%).
PbROM1 gene disruption
To gain insights on PbROM1 function we disrupted the gene by
homologous recombination and investigated the effects of gene
loss on parasite development. Gene disruption was achieved by
inserting a DNA fragment encoding a drug resistance marker into
the open reading frame of PbROM1 (Figure 3A). Gene disruption
was confirmed by insertion-specific PCR that identifies the
disrupted locus from the wild-type locus (Figure 3B). In addition,
disruption was confirmed by the absence of the transcript in
PbROM1(2) sporozoites (Figure 3C).
PbROM1 is required for efficient transition of ookinetes
into oocysts but is not required for sporozoite invasion of
salivary glands
We examined the possible function of PbROM1 in ookinetes by
feeding PbROM1(2) parasites to mosquitoes. Ookinete efficiency
of midgut invasion was assessed by counting the resulting number
of oocysts. Disruption of the PbROM1 gene did not affect
ookinete formation (Figure 4A and Table S1). However, in 6/7
experiments we found strong reduction in oocyst numbers
(Figure 4B and Tables S2 and S3). These results suggest that loss
of PbROM1 function impairs the ability of ookinetes to form
oocysts. Subsequent development of PbROM1(2) parasites
appears to be normal. The number of sporozoites formed by
PbROM1(2) oocysts was similar to wild-type oocysts and no
differences of salivary gland invasion could be detected (Figure 4C
Figure 2. Immuno-electron microscopic localization of PbROM1 in salivary gland sporozoites. (A,B) Immunogold labeling of merozoites.
PbROM1 is detected in the apical end (arrows) of merozoites within secretory organelles, predominantly within micronemes (Mi). The insert in panel B
shows a microneme from another merozoite labeled with gold particles. (C,D) Immunogold labeling with anti-PbROM1 antibody of P. berghei-
infected mosquito salivary gland sporozoite cryosections. The protein is detected on the parasite plasma membrane (PM) as well as on the
membrane of micronemes (Mi) (see text for distribution statistics). The typical folded posterior end seen in sporozoites is marked with asterisk. DG:
dense granule, SD: salivary duct, N: Nucleus, R: Rhoptries. (Scale bars, 250 nm).
doi:10.1371/journal.ppat.1000262.g002
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ROM1 protein expression in midgut sporozoites (Figure 1B).
PbROM1(2) sporozoites infect the liver less efficiently
To investigate whether PbROM1 plays a role in liver infection,
we injected mice intravenously with an equal number of WT and
PbROM1(2) sporozoites. The efficiency of infection was dose
dependent and mice infected with PbROM1(2) parasites showed
a consistent delay in the pre-patent period by one day or more
compared to mice infected with wild-type sporozoites (Table 1).
Efficiency of infection was also assessed by quantifying parasite
loads in livers infected with equal numbers of mutant or wild-type
sporozoites. Livers of mice infected with the mutant sporozoite
had a 68% lower parasite load compared with mice infected with
wild-type sporozoites (Figure 4D). This suggests that PbROM1 is
required for efficient hepatocyte infection.
PbROM1 is not required for gliding motility
To determine if the defect observed in hepatocyte infection is
due to a defect in motility, we performed a sporozoite gliding
assay. PbROM1(2) sporozoites are motile as observed by
circumsporozoite protein trails on glass slides (Figure 5C).
PbTRAP, the parasite adhesin essential for gliding motility [41],
is proteolytically processed by a serine protease (Figure 5A
[42,43]). This processing appears to occur independent of
ROM1 (Figure 5B). This suggests that the reduction in parasite
numbers may not be due to impairment in motility but rather a
defect in invasion and/or a subsequent defect in development.
PbROM1 disruptant parasites are impaired in blood stage
infection
Parasitemia develops slower in animals infected with
PbROM1(2) parasites compared to WT infected animals
(Figure 6A and 6B). This phenotype is observed in animals
infected by injection of sporozoites (Figure 6A) as well as when
bypassing liver invasion by injecting infected RBCs (iRBCs)
(Figure 6B). This slow-growth phenotype is specific to PbROM1
disruptants as another rhomboid (ROM3) disruptant and an
oocyst capsule protein disruptant [44] have growth kinetics similar
to wild-type parasites (data not shown).
Figure 3. PbROM1 gene disruption. (A) Schematic representation of the targeting strategy. The wild-type PbROM1 genomic locus (WT) was
targeted with an NdeI-linearized plasmid (pROM1) containing the 59 and 39 truncations of the PbROM1 open reading frame and the TgDHFR positive
selection marker. Upon a single crossover event, the region of homology is duplicated, resulting in two truncated, nonexpressed PbROM1 copies in
the integrated locus [PbROM1(2)]. The homologous regions in the disruption plasmid are shaded gray. Arrowheads indicate primer pairs used to
confirm gene disruption. Hatched areas represent the region of the ORF that is outside the homologous region. (B) Integration-specific PCR analysis.
Genomic DNA was prepared from wild-type P. berghei and drug resistant parasite clones and PCR was performed using the primer pairs indicated in
panel A. The presence of the 1.2 kb integration-specific PCR product (P3/P2) but not the 1.7 kb WT locus-specific PCR product (P1/P2) in the
PbROM1(2) lanes confirm gene disruption. Note that WT lanes show the presence of the wild-type locus (P1/P2) as expected but not the integration
locus (P3/P2). (C) RT-PCR confirmation of PbROM1 disruption. Salivary gland sporozoites from PbROM1(2)-infected mosquitoes did not express
PbROM1, as expected. PbCS was used as a positive control and can be seen expressed in both WT and PbROM1(2) sporozoites.
doi:10.1371/journal.ppat.1000262.g003
Plasmodium Rhomboid 1 and Malaria
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lifespan
Mice infected with PbROM1(2) parasites survive better than
those infected with WT parasites (Figure 6C). Animals infected
with PbROM1(2) parasites reach peak parasitemia of .35%,
similar to WT parasites. At such high parasitemia, animals
infected with WT parasites succumb to the infection. On the other
hand, more than 80% of animals infected with PbROM1(2)
parasites survive and eventually clear the parasites from their
blood stream.
PbROM1(2) infection protects mice from challenge with
a lethal dose of wild-type parasites
Mice that had cleared PbROM1(2) parasites from their
bloodstream were challenged by intravenous injection of 10
5
WT iRBCs at least 30 d after the last circulating parasite was
detected. Peak parasitemia in 12/14 mice after WT challenge
ranged between 0.004%–2.6% (Figure 6D). Importantly, all the
animals were able to successfully clear the wild-type parasites
Figure 4. PbROM1 is required for efficient infection of mosquito midgut and mouse hepatocytes. (A) PbROM1 is not required for ookinete
formation. Individual midguts from mosquitoes fed either on WT- or ROM1(2)-infected mice were analyzed for ookinete numbers. ROM1(2) parasites
differentiated into ookinetes as efficiently as wild-type parasites (P.0.05, unpaired t test). (B) PbROM1(2) ookinetes are impaired in the ability to form
oocysts. In six out of seven experiments, mosquitoes fed on mice infected with ROM1(2) parasites formed significantly fewer oocysts compared to
four out of five experiments using mice infected with WT parasites. Experiments labeled ROM1(2)4, ROM1(2)5 and ROM1(2)6 were performed using
an independent clone. Oocysts were counted on day 15 after blood feeding (*: P,0.05, ANOVA, Tukey’s multiple comparison test). (C) PbROM1 is not
required for efficient invasion of mosquito salivary glands. Sporozoites were isolated from midguts and salivary glands of mosquitoes (day 25–26)
infected with WT and ROM1(2) parasites and counted on a hemocytometer. To estimate the efficiency of sporozoite infection of salivary glands, total
midgut sporozoites were normalized for prevalence (mosquito infectivity) and mean oocysts per mosquito (day 15) for each experiment (P .0.05,
unpaired t test). Bars show mean6SEM. (D) ROM1 is required for efficient infection of the mouse liver. The same number (1000) of WT or ROM1(2)
salivary gland sporozoites were injected intravenously into mice and the efficiency of liver infection was measured 36 h later by quantitative PCR of P.
berghei 18S rRNA normalized using mouse GAPDH (P,0.05, unpaired t test). Parasite load in livers of mice infected with mutant sporozoites was 68%
lower than in livers infected by wild-type sporozoites.
doi:10.1371/journal.ppat.1000262.g004
Table 1. Prepatent period of blood infection is longer for
mice infected with PbROM1(2) sporozoites
Parasite population Rate of infection Prepatent period
WT-150 7/8 5.1
WT-1000 7/7 4.8
WT-10000 3/3 3.3
ROM1(2)-150 0/8
ROM1(2)-1000 6/8 5.7
ROM1(2)-10000 6/6 4.8
Mice were injected intravenously with the indicated number of wild-type (WT)
or PbROM1(2) salivary gland sporozoites. Rate of infection is expressed as the
number of mice infected/total number of mice injected with sporozoites. Pre-
patent period is the number of days between sporozoite injection and the
appearance of blood stage parasites upon examination of at least 25,000 RBCs.
doi:10.1371/journal.ppat.1000262.t001
Plasmodium Rhomboid 1 and Malaria
PLoS Pathogens | www.plospathogens.org 6 January 2009 | Volume 5 | Issue 1 | e1000262(Table 2). This protective immunity lasts for at least 7–9 months
after the initial PbROM1(2) parasite exposure (Table 2). It is
possible that the reduced RBC invasion efficiency of PbROM1(2)
merozoites may trigger this protective immune response.
Discussion
Invasion requires the specific recognition and attachment of
parasite surface ligands to host cell receptors and subsequent
processing of the bound ligands to facilitate detachment and entry
into the host cell. This can be achieved by proteolytic processing of
protein ectodomains [19] or in some cases by processing within the
protein’s transmembrane domain [18]. Plasmodium AMA1, EBL,
RBL and TRAP proteins function in host-cell interaction and all
have potential rhomboid cleavage sites within their predicted
transmembrane domains. Recent studies using an in vitro
mammalian cell-based assay indicate that Plasmodium ROM1 and
ROM4 are able to cleave AMA1, EBL, RBL and TRAP members
within their membrane-spanning domains [26,28]. This suggests
an important function for rhomboid proteins in invasion of host
cells. In the present study we undertook a genetic approach to
investigate the role of Plasmodium berghei rhomboid 1 (PbROM1)
during the parasite development in the mammalian host and the
mosquito vector.
Microarray analysis of P. falciparum genes identified PfROM1 as
being expressed in both the mosquito and the asexual forms of the
parasite [39]. Similarly, P. berghei ROM1 is also expressed in the
mosquito and in its mammalian host [29,40]. In agreement with
the mRNA expression data, we find PbROM1 protein to be
expressed in schizonts, in free merozoites and in sporozoites after
salivary gland invasion. Though PbROM1 transcripts can be
found in ookinetes (Figure S2), we could not detect the protein by
indirect immunofluorescence. This may be due to the low
abundance of the protein in this parasite form. The difference in
PbROM1 protein expression between midgut and salivary gland
sporozoites suggests post-transcriptional gene regulation. Incom-
pletely spliced PbROM1 transcripts can be found in mature
oocysts and sporozoites isolated from these oocysts (Figure S2).
Furthermore, the ROM1 mRNA may be translationally regulated.
Post-transcriptional regulation has been observed for a number of
genes, especially in the sexual stages and plays an important role in
Plasmodium development [29,45,46].
Our genetic analysis indicates that PbROM1 functions in both
the vertebrate and mosquito stages. This is based on the
observation that PbROM1(2) ookinetes form fewer oocysts,
sporozoites isolated from infected mosquitoes infect the mouse
liver less efficiently and the growth kinetics of the asexual forms is
significantly delayed. Hence the phenotype of PbROM1(2)
parasites points to ROM1 roles during cell invasion. However, a
role in intracellular development cannot be formally excluded. We
believe this to be less likely for several reasons. First, the mutant
parasites fully complete development after invasion of the
mosquito midgut epithelium, mouse liver and mouse RBCs.
Second, WT and ROM1(2) ookinetes (Table S1), sporozoites
(Table S2) and blood-stage merozoites (data not shown) develop
equally well. Third, the ROM1 protein localizes to merozoite and
sporozoite micronemes (an organelle that secrete proteins involved
in invasion), in addition to the sporozoite surface. Together, these
observations point to a role for ROM1 in host cell invasion.
Mice infected with PbROM1(2) parasites survive longer and
are able to clear the infection efficiently. Those that clear the
infection develop long-lasting immunity against a subsequent
lethal wild-type P. berghei challenge. The immunity developed by
PbROM1(2)-infected mice could be a result of slower infection,
which provides the animal with an opportunity to mount a better
immune response. Another interesting possibility is that parasite
proteins normally processed by PbROM1 during invasion
modulate the immune response. The absence or reduced levels
of these cleaved proteins would allow the animals to develop
immunity against the parasite. Interestingly, the Toxoplasma gondii
ROM1 orthologue has also been shown to be required for efficient
growth and invasion of host cells [47]. In addition to its role in
invasion, TgROM1 also appears to play a role in intracellular
replication as they form fewer parasites within the parasitophorous
Figure 5. PbTRAP is not a substrate for PbROM1. (A) PbTRAP is cleaved by a serine protease. Total cell lysate from 3610
4 salivary gland
sporozoites was loaded in each lane of a 4–25% denaturing SDS-PAGE. Western blot was performed using an anti-PbTRAP-repeat rabbit polyclonal
antibody. The TRAP fragment recognized by the anti-repeat antibody but not by antibody against the cytoplasmic tail is indicated with an asterisk.
Ctrl, control; E, empty lane. (B) PbTRAP processing in PbROM1(2) sporozoites. Experiments with 3610
4 sporozoites/lane were conducted as described
for experiments in panel A with wild-type (WT) and mutant parasites. (C) Gliding motility of PbROM1(2) sporozoites. PbROM1(2) salivary gland
sporozoites were placed in a 2-well chamber slide coated with BSA and incubated at 37uC for 30 min. After fixation with paraformaldehyde CSP trails
were detected with an anti-CSP antibody (3D11) and a rhodamine-conjugated anti-mouse secondary antibody. *, sporozoite at the leading end of the
trail.
doi:10.1371/journal.ppat.1000262.g005
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protected from a WT parasite challenge. Swiss Webster mice were injected intravenously with 1,000 wild-type (WT) or PbROM1(2) salivary
gland sporozoites (Spz) (A) or intraperitonealy with 10
5 infected RBCs (iRBC) (independent clone (B)) and parasitemia was measured daily and
expressed as mean of two consecutive days. Three to four mice were used for each group and parasitemia is expressed as mean6SEM. The dotted
line represents the point beyond which parasitemia in WT and ROM1(2) differed significantly (P,0.05, repeated measures ANOVA). (C) Survival of
mice infected with either wild-type (WT) or PbROM1(2) sporozoites. Swiss Webster mice were injected intravenously with the indicated number of either
WT or PbROM1(2) sporozoites and animal survival was monitored daily. PbROM1(2) infected mice survive significantly longer than WT infected mice
(P,0.0001). Numbers in parenthesis indicate the number of mice assayed. (D) Mice that clear PbROM1(2) infection are protected from WT parasite
challenge. Mice (M) from three experiments (E) such as the ones described in panel A and B that had survived PbROM1(2) infection and cleared the
parasites were re-infected by either a) intravenous (i.v) injection of 10
4 wild-type sporozoites (E1), b) intra-peritoneal injection of 10
6 infected RBCs
(E2), or c) intra-venous injection of 10
6 infected RBCs (E3) at least 30 days after the clearance of the original PbROM1(2) infection. Seven out of 14
mice developed very mild parasitemia (0.004%–2.6%) that was subsequently completely cleared. These mice were also protected from a subsequent
2
nd and a 3
rd WT parasite challenge (Table 2).
doi:10.1371/journal.ppat.1000262.g006
Table 2. PbROM1(2) parasites generate protective immunity
Expt PbROM1(2) infection No. parasites 1
st challenge (10
5)2
nd challenge (10
5)3
rd challenge (10
5)
Infected Protected Infected Protected Infected Protected
1 Sporozoite 10
4 3/4 (30d) 4/4 (30d) 4/4 (60d) 4/4 (60d) 4/4 (9m) 4/4 (9m)
2 iRBC (i.p)1 0
6 1/3 (30d) 3/3 (30d) 3/3 (60d) 3/3 (60d) 3/3 (9m) 3/3 (9m)
3 iRBC (i.p)1 0
6 3/7 (30d) 7/7 (30d) 5/7 (7m) 7/7 (7m)
Swiss Webster mice were infected with PbROM1(2) either by intravenous injection of sporozoites or intravenous or intraperitoneal (i.v or i.p) administration of iRBCs (cf.
Figure 5D). Animals that cleared PbROM1(2) infection (Figure 5D) were used for wild-type parasite challenges at least 30 days after the last observed parasite.
PbROM1(2) parasite clearance was confirmed by transfer of 3610
7 RBCs from all parasite-free animals to naı ¨ve mice. None became infected. These mice were then
challenged intravenously with 10
5 wild-type P. berghei iRBCs and monitored for infection. All the animals were protected (1
st challenge). These animals were also
protected from a second and third challenge. Numbers in parenthesis indicates the number of days (d) or months (m) after the last PbROM1(2) parasite was observed.
Infected, number of animals that had blood stage parasites; Protected, number of animals that cleared the blood-stage infection.
doi:10.1371/journal.ppat.1000262.t002
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significant role in the development neither of sporozoites within
oocysts (Table S4) nor of merozoites within schizonts (data not
shown). However, a role for PbROM1 in parasite replication in
the mouse liver cannot be excluded. The observed differences
between Plasmodium and Toxoplasma could represent a species-
specific difference of ROM1 function.
Even though PbROM1(2) parasites are defective in multiple
invasive stages, they do complete their life cycle successfully in both
the vertebrate and invertebrate hosts. It is possible that in
PbROM1(2) parasites, impairment of proteolytic processing only
delays parasite invasion. Alternatively or in addition, other rhomboid
proteins and/or proteases may take over the function of PbROM1,
albeit with lower efficiency. There is precedent for such redundant
function from inv i t r odata suggesting that some substrates are cleaved
well by either PfROM1 or PfROM4, while other substrates are
cleaved by both enzymes, albeit at different efficiencies [26]. A
number of candidate substrates for PbROM1 such as AMA1 have
been identified using mammalian cell-based assays [26]. However,
these would have to be validated by in vivo experiments and factors
such as spatial and temporal regulation of the protease and its
substrate(s) are also expected to play a role. Our results suggest that
PbTRAP, the parasite adhesin required for sporozoite motility, is
cleaved by a serine protease. The protease inhibitors used does not
necessarily inhibit only TRAP processing, but would be expected to
inhibit several other serine proteases. However, the assay specifically
measures only TRAP processing. TRAP is processed in the absence
of ROM1 suggesting that it might not be a substrate. Alternatively, as
discussed above, TRAP processing in ROM1(2)p a r a s i t e sc o u l db e
due to functional redundancy. Data from in vitro processing assays
suggest that this is unlikely because ROM4 but not ROM1 was able
to cleave TRAP [26].
In conclusion, this study points to distinct roles for Plasmodium
berghei ROM1 throughout parasite development. The lack of an
effective vaccine is attributed to the high degree of antigenic
variation [48] and the ability of the parasite to switch invasion
pathways [49–52]. On the other hand, a common phenomenon in
the different invasion pathways could be the need for processing
and release of the adhesins. For instance, processing of EBA175
within the membrane domain is essential for invasion [28]. As
suggested by our genetic analysis, targeting rhomboid proteins
offers an attractive new approach to the control of malaria.
Supporting Information
Figure S1 Conservation of catalytic residues between Plasmodium
and Drosophila ROM1. The essential Drosophila Asparagine-Serine-
Histidine catalytic triad (rhomboid motif), is conserved in
Plasmodium ROM1 (asterisk). Other surrounding amino acids
shown are also important for rhomboid protein function in
Drosophila. The catalytic residues are predicted to be present within
the transmembrane domains (shaded gray). P. berghei: Plasmodium
berghei; Py: Plasmodium yoelli; Pf: Plasmodium falciparum; Dm:
Drosophila melanogaster. The number of amino acids of each protein
is indicated to the right.
Found at: doi:10.1371/journal.ppat.1000262.s001 (0.03 MB PDF)
Figure S2 Gene structure of PbROM1. The top diagram shows
the canonical intron/exon structure of PbROM1 (exons in blue).
EST sequences available from Genbank and PlasmoDB for
gradient-purified ookinetes (yellow), sporozoites purified from
either infected midguts (orange) or salivary glands (red) and from
developing oocysts (brown) are shown below the PbROM1
structure. Genbank accession numbers are given alongside each
EST. Incompletely spliced forms can be observed in the
developing oocyst (day 10–12) and midgut sporozoites
(CB603492 and DC216124).
Found at: doi:10.1371/journal.ppat.1000262.s002 (0.06 MB PDF)
Table S1 PbROM1 is not required for ookinete formation
Found at: doi:10.1371/journal.ppat.1000262.s003 (0.03 MB PDF)
Table S2 PbROM1 is required for efficient infection of the
mosquito
Found at: doi:10.1371/journal.ppat.1000262.s004 (0.06 MB PDF)
Table S3 One way ANOVA test for assessing statistical
significance of differences in WT and ROM1(2) oocyst numbers
Found at: doi:10.1371/journal.ppat.1000262.s005 (0.05 MB PDF)
Table S4 PbROM1 is not required for sporozoite invasion of
mosquito salivary glands
Found at: doi:10.1371/journal.ppat.1000262.s006 (0.05 MB PDF)
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